{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:34:35Z","timestamp":1792272875491,"version":"4.4.0"},"reference-count":237,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neurobiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.pneurobio.2015.12.003","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T07:15:48Z","timestamp":1453101348000},"page":"4-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"special_numbering":"C","title":["Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease"],"prefix":"10.1016","volume":"151","author":[{"given":"Lhassane","family":"Ismaili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Refouvelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Benchekroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Brogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Brindisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gemma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Campiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Filipic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danica","family":"Agbaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Unzeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3277-1139","authenticated-orcid":false,"given":"Stefania","family":"Butini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Marco-Contelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pneurobio.2015.12.003_bib0005","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10822-013-9699-6","article-title":"Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors","volume":"27","author":"Abuhamdah","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0010","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.abb.2010.12.024","article-title":"Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)","volume":"507","author":"Adayev","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0015","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1006\/jmbi.1997.1245","article-title":"Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils","volume":"272","author":"Alvarez","year":"1997","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmc.2011.12.042","article-title":"A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease","volume":"20","author":"Anand","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0025","doi-asserted-by":"crossref","first-page":"7615","DOI":"10.1021\/jm400990p","article-title":"Divergent structure\u2013activity relationships of structurally similar acetylcholinesterase inhibitors","volume":"56","author":"Andersson","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0030","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease","volume":"52","author":"Arce","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0035","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejmech.2013.10.024","article-title":"Novel coumarin-3-carboxamides bearing N-benzylpiperidine moiety as potent acetylcholinesterase inhibitors","volume":"70","author":"Asadipour","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-4159.2006.04258.x","article-title":"Therapeutic targets and potential of the novel brain-permeable multifunctional iron chelator-monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer's disease","volume":"100","author":"Avramovich-Tirosh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0045","first-page":"2","article-title":"Pharmacophore modeling, virtual and in vitro screening for acetylcholinesterase inhibitors and their effects on amyloid-beta self-assembly","volume":"9","author":"Bag","year":"2013","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0050","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1073\/pnas.1301814110","article-title":"Free energy landscape for the binding process of Huperzine A to acetylcholinesterase","volume":"110","author":"Bai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0055","doi-asserted-by":"crossref","first-page":"4949","DOI":"10.2174\/092986711797535245","article-title":"Multi-target-directed ligands in Alzheimer's disease treatment","volume":"18","author":"Bajda","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0060","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-based search for new inhibitors of cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0065","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-2952(02)01514-9","article-title":"\u03b2-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies","volume":"65","author":"Bartolini","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejmech.2013.12.028","article-title":"Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase\/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease","volume":"75","author":"Bautista-Aguilera","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0075","first-page":"1893","article-title":"Multipotent cholinesterase\/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids","volume":"8","author":"Bautista-Aguilera","year":"2014","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0080","doi-asserted-by":"crossref","DOI":"10.1021\/jm501501a","article-title":"N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine, a new cholinesterase and monoamine oxidase dual inhibitor","author":"Bautista-Aguilera","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0085","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/cmdc.201402409","article-title":"Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids","volume":"10","author":"Benchekroun","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4155\/fmc.14.148","article-title":"Donepezil-ferulic acid hybrids as anti-Alzheimer drugs","volume":"7","author":"Benchekroun","year":"2015","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic A\u03b2 oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0100","doi-asserted-by":"crossref","first-page":"e0121092","DOI":"10.1371\/journal.pone.0121092","article-title":"A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations","volume":"10","author":"Bennion","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0076-6879(99)99005-5","article-title":"Ferric reducing\/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration","volume":"299","author":"Benzie","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0110","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1523\/JNEUROSCI.16-03-01193.1996","article-title":"Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors","volume":"16","author":"Bergeron","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0115","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2174\/092986711795029681","article-title":"In silico methods to assist drug developers in acetylcholinesterase inhibitor design","volume":"18","author":"Bermudez-Lugo","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0120","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nature11691","article-title":"Automated design of ligands to polypharmacological profiles","volume":"492","author":"Besnard","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0125","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2174\/15672050113109990151","article-title":"Multipotent, permeable drug ASS234 inhibits Abeta aggregation, possesses antioxidant properties and protects from Abeta-induced apoptosis in vitro","volume":"10","author":"Bolea","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0130","doi-asserted-by":"crossref","first-page":"8251","DOI":"10.1021\/jm200853t","volume":"54","author":"Bolea","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0135","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/jm701225u","article-title":"Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease","volume":"50","author":"Bolognesi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0140","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/cns.12290","article-title":"Disease-modifying anti-Alzheimer's drugs: inhibitors of human cholinesterases interfering with beta-amyloid aggregation","volume":"20","author":"Brogi","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ejmech.2010.11.034","article-title":"Three-dimensional quantitative structure\u2013selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2","volume":"46","author":"Brogi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0150","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1021\/ci900254b","article-title":"Pharmacophore modeling for qualitative prediction of antiestrogenic activity","volume":"49","author":"Brogi","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0155","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejmech.2013.06.048","article-title":"3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors","volume":"67","author":"Brogi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0160","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0006-3495(03)74651-7","article-title":"The dynamics of ligand barrier crossing inside the acetylcholinesterase gorge","volume":"85","author":"Bui","year":"2003","journal-title":"Biophys. J."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0165","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1021\/ja0485715","article-title":"Acetylcholinesterase: enhanced fluctuations and alternative routes to the active site in the complex with fasciculin-2","volume":"126","author":"Bui","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0170","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/ml4002908","article-title":"Multifunctional cholinesterase and amyloid Beta fibrillization modulators. Synthesis and biological investigation","volume":"4","author":"Butini","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0175","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2174\/15680266113139990137","article-title":"The structural evolution of beta-secretase inhibitors: a focus on the development of small-molecule inhibitors","volume":"13","author":"Butini","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0180","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1021\/jm701253t","article-title":"Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors","volume":"51","author":"Butini","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2013.09.056","article-title":"A stereoselective approach to peptidomimetic BACE1 inhibitors","volume":"70C","author":"Butini","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0190","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1016\/j.bmcl.2008.08.076","article-title":"Tacrine based human cholinesterase inhibitors: synthesis of peptidic-tethered derivatives and their effect on potency and selectivity","volume":"18","author":"Butini","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0195","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/jm049510k","article-title":"Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE), Rational design of novel, selective, and highly potent BuChE inhibitors","volume":"48","author":"Campiani","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0026-895X(24)23214-4","article-title":"Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease","volume":"57","author":"Camps","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0205","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejmech.2013.01.044","article-title":"Synthesis and structure\u2013activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds","volume":"63","author":"Cappelli","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0210","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1021\/jm990224w","article-title":"Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions","volume":"42","author":"Carlier","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0968-0896(98)00213-2","article-title":"Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis","volume":"7","author":"Carlier","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0220","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2174\/15680266113139990135","article-title":"The multifactorial nature of Alzheimer's disease for developing potential therapeutics","volume":"13","author":"Carreiras","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1124\/jpet.111.186460","article-title":"Characterization of COR627 and COR628, two novel positive allosteric modulators of the GABA(B) receptor","volume":"340","author":"Castelli","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0230","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bmc.2012.10.045","article-title":"Design, synthesis and biological evaluation of coumarin alkylamines as potent and selective dual binding site inhibitors of acetylcholinesterase","volume":"21","author":"Catto","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0235","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.bmcl.2012.08.036","article-title":"Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease","volume":"22","author":"Chao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0240","doi-asserted-by":"crossref","first-page":"6490","DOI":"10.1021\/jm100573q","article-title":"Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology","volume":"53","author":"Chaudhaery","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0245","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0250","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1016\/j.bmcl.2012.03.046","article-title":"Discovery of a novel acetylcholinesterase inhibitor by structure-based virtual screening techniques","volume":"22","author":"Chen","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0255","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/jm300106z","article-title":"Tacrine-ferulic acid-nitric oxide (NO) donor trihybrids as potent, multifunctional acetyl- and butyrylcholinesterase inhibitors","volume":"55","author":"Chen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0260","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ardp.201300074","article-title":"Tacrine-flurbiprofen hybrids as multifunctional drug candidates for the treatment of Alzheimer's disease","volume":"346","author":"Chen","year":"2013","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0265","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1021\/jm4004285","article-title":"QSAR modeling: where have you been? Where are you going to?","volume":"57","author":"Cherkasov","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0270","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0275","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/S0960-894X(02)00482-1","article-title":"Quaternary salts of E2020 analogues as acetylcholinesterase inhibitors for the reversal of neuromuscular block","volume":"12","author":"Clark","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0280","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1021\/jm001088u","article-title":"Design, synthesis, and structure\u2013activity relationships of a series of 3-[2-(1-benzylpiperidin-4-yl)ethylamino]pyridazine derivatives as acetylcholinesterase inhibitors","volume":"44","author":"Contreras","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0285","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/jm981101z","article-title":"Aminopyridazines as acetylcholinesterase inhibitors","volume":"42","author":"Contreras","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0290","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1021\/ja809117z","article-title":"On the mechanism of Trolox as antiblinking and antibleaching reagent","volume":"131","author":"Cordes","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0295","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10822-011-9495-0","article-title":"The inevitable QSAR renaissance","volume":"26","author":"Cramer","year":"2012","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0165-0173(02)00219-9","article-title":"Zinc takes the center stage: its paradoxical role in Alzheimer's disease","volume":"41","author":"Cuajungco","year":"2003","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0305","first-page":"60","article-title":"Treatment of Alzheimer's disease: current and future therapeutic approaches","volume":"1","author":"Cummings","year":"2004","journal-title":"Rev. Neurol. Dis."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0310","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1476-5381.2012.02057.x","article-title":"Alzheimer's disease, beta-amyloid, glutamate, NMDA receptors and memantine \u2013 searching for the connections","volume":"167","author":"Danysz","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0315","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/jf0305231","article-title":"Extending applicability of the oxygen radical absorbance capacity (ORAC-fluorescein) assay","volume":"52","author":"Davalos","year":"2004","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0006-8993(94)01294-R","article-title":"Sigma receptor-mediated neuroprotection against glutamate toxicity in primary rat neuronal cultures","volume":"671","author":"DeCoster","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0325","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/cns.12269","article-title":"Wnt signaling pathway, a potential target for Alzheimer's disease treatment, is activated by a novel multitarget compound ASS234","volume":"20","author":"del Pino","year":"2014","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0330","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1021\/jm1013709","article-title":"Homoisoflavonoids: natural scaffolds with potent and selective monoamine oxidase-B inhibition properties","volume":"54","author":"Desideri","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0335","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/ja00299a024","article-title":"Development and use of quantum mechanical molecular models, 76. AM1: a new general purpose quantum mechanical molecular model","volume":"107","author":"Dewar","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood-brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0345","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmech.2013.12.008","article-title":"1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies","volume":"73","author":"Di Pietro","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0350","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1016\/j.bmc.2013.02.047","article-title":"Investigation of the role of linker moieties in bifunctional tacrine hybrids","volume":"21","author":"Eckroat","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0355","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1021\/tx400138s","article-title":"Nontoxic and neuroprotective beta-naphthotacrines for Alzheimer's disease","volume":"26","author":"Esquivias-Perez","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0360","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.bbapap.2014.03.006","article-title":"Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease","volume":"1844","author":"Esteban","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0365","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1021\/jm801131a","article-title":"NO-donating tacrine hybrid compounds improve scopolamine-induced cognition impairment and show less hepatotoxicity","volume":"51","author":"Fang","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0370","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1021\/jm701491k","article-title":"Synthesis and biological evaluation of NO-donor-tacrine hybrids as hepatoprotective anti-Alzheimer drug candidates","volume":"51","author":"Fang","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0375","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1016\/j.bmcl.2008.03.073","article-title":"Design and synthesis of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates","volume":"18","author":"Fang","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0380","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1021\/jm201460y","article-title":"New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and beta-amyloid-reducing properties","volume":"55","author":"Fernandez-Bachiller","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0385","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1021\/bi002892l","article-title":"Beta D305A mutant of tryptophan synthase shows strongly perturbed allosteric regulation and substrate specificity","volume":"40","author":"Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0390","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2014.02.010","article-title":"Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release","volume":"143","author":"Finberg","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0395","doi-asserted-by":"crossref","first-page":"e19264","DOI":"10.1371\/journal.pone.0019264","article-title":"beta-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites","volume":"6","author":"Frost","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0400","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1021\/jm200840c","article-title":"Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases","volume":"55","author":"Galdeano","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0405","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1039\/C3RA45933K","article-title":"From (+)-epigallocatechin gallate to a simplified synthetic analogue as a cytoadherence inhibitor for P. falciparum","volume":"4","author":"Gemma","year":"2014","journal-title":"RSC Adv."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0410","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/1062936X.2013.792877","article-title":"Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors","volume":"24","author":"Gharaghani","year":"2013","journal-title":"SAR QSAR Environ. Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0415","series-title":"Chemical Papers","first-page":"677","article-title":"Flexibility of active-site gorge aromatic residues and non-gorge aromatic residues in acetylcholinesterase","author":"GhattyVenkataKrishna","year":"2013"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0001","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bmcl.2014.11.087","article-title":"Structure-based design, synthesis and biological evaluation of novel \u03b2-secretase inhibitors containing a pyrazole or thiazole moiety as the P3 ligand","volume":"25","author":"Ghosh","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0420","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1016\/j.bmcl.2014.05.044","article-title":"Rational design of the first difluorostatone-based PfSUB1 inhibitors","volume":"24","author":"Giovani","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0425","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/jm00034a020","article-title":"Structural features important for sigma 1 receptor binding","volume":"37","author":"Glennon","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0430","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0376-8716(95)01134-K","article-title":"The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample","volume":"39","author":"Grant","year":"1995","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0435","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0440","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bmcl.2010.12.131","article-title":"Discovery of dual binding site acetylcholinesterase inhibitors identified by pharmacophore modeling and sequential virtual screening techniques","volume":"21","author":"Gupta","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0445","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1021\/jm100600y","article-title":"Development, validation, and use of quantitative structure\u2013activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs","volume":"53","author":"Hajjo","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0450","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/jm2011657","article-title":"Chemocentric informatics approach to drug discovery: identification and experimental validation of selective estrogen receptor modulators as ligands of 5-hydroxytryptamine-6 receptors and as potential cognition enhancers","volume":"55","author":"Hajjo","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0455","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1021\/cr3000994","article-title":"The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization","volume":"112","author":"Hamley","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0460","doi-asserted-by":"crossref","first-page":"7073","DOI":"10.1021\/jm5008648","article-title":"Synthesis and biological evaluation of novel tacrine derivatives and tacrine-coumarin hybrids as cholinesterase inhibitors","volume":"57","author":"Hamulakova","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0465","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/194178b0","article-title":"Correlation of biological activity of phenoxyacetic acids with Hammett substituent constants and partition coefficients","volume":"194","author":"Hansch","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0470","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1073\/pnas.90.19.9031","article-title":"Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase","volume":"90","author":"Harel","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0475","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1016\/S0960-894X(99)00540-5","article-title":"Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands","volume":"9","author":"Haubmann","year":"1999","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0480","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0922-4106(94)90115-5","article-title":"Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling","volume":"268","author":"Hellewell","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0485","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1110\/ps.0214002","article-title":"Structural and dynamic properties of water around acetylcholinesterase","volume":"11","author":"Henchman","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0490","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/S0006-3495(02)75609-9","article-title":"Properties of water molecules in the active site gorge of acetylcholinesterase from computer simulation","volume":"82","author":"Henchman","year":"2002","journal-title":"Biophys. J."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0495","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/jm0304008","article-title":"Design and synthesis of hydroxyethylene-based peptidomimetic inhibitors of human beta-secretase","volume":"47","author":"Hom","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0500","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","article-title":"Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor","volume":"290","author":"Hong","year":"2000","journal-title":"Science (New York, N Y)"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0505","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bmc.2012.11.044","article-title":"Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors","volume":"21","author":"Hu","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0510","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1016\/j.bmc.2011.09.061","article-title":"Searching for the multi-target-directed ligands against Alzheimer's disease: discovery of quinoxaline-based hybrid compounds with AChE, H(3)R and BACE 1 inhibitory activities","volume":"19","author":"Huang","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0515","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1021\/jm980032l","article-title":"Synthesis and quantitative structure\u2013activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands","volume":"41","author":"Huang","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0520","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1021\/jm010384j","article-title":"Synthesis and structure\u2013activity relationships of N-(1-benzylpiperidin-4-yl)arylacetamide analogues as potent sigma1 receptor ligands","volume":"44","author":"Huang","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0525","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/S0968-0896(01)00175-4","article-title":"Synthesis of 2-(2,3-dimethoxyphenyl)-4-(aminomethyl)imidazole analogues and their binding affinities for dopamine D(2) and D(3) receptors","volume":"9","author":"Huang","year":"2001","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0530","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2174\/156720511797633232","article-title":"Genetic polymorphisms in sigma-1 receptor and apolipoprotein E interact to influence the severity of Alzheimer's disease","volume":"8","author":"Huang","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0535","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1007\/s00044-014-0931-2","article-title":"Design and synthesis of tacrine-phenothiazine hybrids as multitarget drugs for Alzheimer's disease","volume":"23","author":"Hui","year":"2014","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0540","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0014-2999(96)00851-5","article-title":"Role of (+)-SKF-10,047-sensitive sub-population of sigma 1 receptors in amelioration of conditioned fear stress in rats: association with mesolimbic dopaminergic systems","volume":"319","author":"Kamei","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0545","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nsb0902-646","article-title":"Molecular dynamics simulations of biomolecules","volume":"9","author":"Karplus","year":"2002","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0550","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0968-0896(96)00137-X","article-title":"The rationale for E2020 as a potent acetylcholinesterase inhibitor","volume":"4","author":"Kawakami","year":"1996","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0555","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1016\/j.bmc.2013.05.028","article-title":"Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease","volume":"21","author":"Keri","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0560","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1021\/jm00022a001","article-title":"Nitric oxide: a new paradigm for second messengers","volume":"38","author":"Kerwin","year":"1995","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0565","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1039\/c3sc51902c","article-title":"A novel hybrid of 6-chlorotacrine and metal-amyloid-[small beta] modulator for inhibition of acetylcholinesterase and metal-induced amyloid-[small beta] aggregation","volume":"4","author":"Kochi","year":"2013","journal-title":"Chem. Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0570","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1110\/ps.03318603","article-title":"Studying the roles of W86, E202, and Y337 in binding of acetylcholine to acetylcholinesterase using a combined molecular dynamics and multiple docking approach","volume":"12","author":"Kua","year":"2003","journal-title":"Protein Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0575","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1021\/ja020429l","article-title":"Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach","volume":"124","author":"Kua","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0580","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1023\/A:1007589808761","article-title":"Toxic effects of tacrine on primary hepatocytes and liver epithelial cells in culture","volume":"14","author":"Lagadic-Gossmann","year":"1998","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0585","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jmgm.2012.12.008","article-title":"Identification of potential bivalent inhibitors from natural compounds for acetylcholinesterase through in silico screening using multiple pharmacophores","volume":"40","author":"Lakshmi","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0590","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.bmc.2014.08.035","article-title":"Design, synthesis and evaluation of novel tacrine-(beta-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"22","author":"Lan","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0595","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/nature07761","article-title":"Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers","volume":"457","author":"Lauren","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0600","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/mp300233y","article-title":"Another brick in the wall. Validation of the sigma1 receptor 3D model by computer-assisted design, synthesis, and activity of new sigma1 ligands","volume":"9","author":"Laurini","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0605","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1039\/c2md20063e","article-title":"Synthesis of dual AChE\/5-HT4 receptor multi-target directed ligands","volume":"3","author":"Lecoutey","year":"2012","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0610","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/med.20248","article-title":"Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease","volume":"33","author":"Leon","year":"2013","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0615","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1039\/C3OB42010H","article-title":"Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease","volume":"12","author":"Li","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0620","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ejmech.2013.09.024","article-title":"Multifunctional tacrine-flavonoid hybrids with cholinergic, beta-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease","volume":"69","author":"Li","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0625","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jmgm.2013.02.003","article-title":"3D-QSAR studies of azaoxoisoaporphine, oxoaporphine, and oxoisoaporphine derivatives as anti-AChE and anti-AD agents by the CoMFA method","volume":"41","author":"Li","year":"2013","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0630","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.ejmech.2013.01.039","article-title":"A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease","volume":"62","author":"Lu","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0635","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1016\/j.ejmech.2011.03.058","article-title":"Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents","volume":"46","author":"Luo","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0640","first-page":"618","article-title":"Inhibition of BACE1 for therapeutic use in Alzheimer's disease","volume":"3","author":"Luo","year":"2010","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0645","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1021\/jm401047q","article-title":"Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen","volume":"56","author":"Luo","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0650","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2010.04.005","article-title":"Correlation between the substrate structure and the rate of acetylcholinesterase hydrolysis modeled with the combined quantum mechanical\/molecular mechanical studies","volume":"187","author":"Lushchekina","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0655","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ejmech.2012.06.038","article-title":"Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease","volume":"54","author":"Maalej","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0660","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1016\/j.bmcl.2011.02.094","article-title":"Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines","volume":"21","author":"Maalej","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0665","doi-asserted-by":"crossref","first-page":"6737","DOI":"10.1016\/j.bmcl.2013.10.034","article-title":"Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity","volume":"23","author":"Mao","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0670","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0675","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1021\/jf305549g","article-title":"In vitro activity-guided identification of antioxidants in aged garlic extract","volume":"61","author":"Matsutomo","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0680","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(97)83020-8","article-title":"SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice","volume":"328","author":"Maurice","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0685","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pharmthera.2009.07.001","article-title":"The pharmacology of sigma-1 receptors","volume":"124","author":"Maurice","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0690","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1600-0404.2005.00432.x","article-title":"Function of sigma1 receptors in Parkinson's disease","volume":"112","author":"Mishina","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0695","doi-asserted-by":"crossref","first-page":"236850","DOI":"10.1155\/2013\/236850","article-title":"Exploring different virtual screening strategies for acetylcholinesterase inhibitors","volume":"2013","author":"Mishra","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0700","doi-asserted-by":"crossref","first-page":"4707","DOI":"10.1016\/j.bmcl.2012.05.077","article-title":"Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template","volume":"22","author":"Mohamed","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0705","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm0706-780","article-title":"Alzheimer disease: progress or profit?","volume":"12","author":"Mount","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0710","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0891-5849(94)00110-6","article-title":"Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study","volume":"18","author":"Naito","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0715","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0197-0186(97)00105-8","article-title":"Activation of sigma1 receptor subtype leads to neuroprotection in the rat primary neuronal cultures","volume":"32","author":"Nakazawa","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0720","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1021\/cr500638n","article-title":"Amyloid beta protein and Alzheimer's disease: when computer simulations complement experimental studies","volume":"115","author":"Nasica-Labouze","year":"2015","journal-title":"Chem. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0725","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1021\/jm5010804","article-title":"Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-beta aggregation and to exert anticholinesterase and antioxidant effects","volume":"57","author":"Nepovimova","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0730","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1021\/ci900182q","article-title":"Multi-assay-based structure\u2013activity relationship models: improving structure\u2013activity relationship models by incorporating activity information from related targets","volume":"49","author":"Ning","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0735","doi-asserted-by":"crossref","first-page":"23730","DOI":"10.1021\/jp0552877","article-title":"Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation","volume":"109","author":"Niu","year":"2005","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0740","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-5-45","article-title":"Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden","volume":"5","author":"O\u2019Leary","year":"2010","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0745","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.bmcl.2012.11.064","article-title":"Synthesis, molecular modeling and evaluation of novel N\u2032-2-(4-benzylpiperidin-\/piperazin-1-yl)acylhydrazone derivatives as dual inhibitors for cholinesterases and Abeta aggregation","volume":"23","author":"Ozturan Ozer","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0750","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1021\/jm3003334","article-title":"Design, synthesis, and pharmacological characterization of indol-3-ylacetamides, indol-3-yloxoacetamides, and indol-3-ylcarboxamides: potent and selective CB2 cannabinoid receptor inverse agonists","volume":"55","author":"Pasquini","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0755","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/138920008784220619","article-title":"Possible role of hydroxylated metabolites of tacrine in drug toxicity and therapy of Alzheimer's disease","volume":"9","author":"Patocka","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0760","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1016\/j.bmc.2012.09.016","article-title":"Acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, A\u03b2 aggregation, and \u03b2-secretase","volume":"20","author":"Peng","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0765","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/sj.bjp.0702600","article-title":"Relevance of benzyloxy group in 2-indolyl methylamines in the selective MAO-B inhibition","volume":"127","author":"Perez","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0770","doi-asserted-by":"crossref","first-page":"e31921","DOI":"10.1371\/journal.pone.0031921","article-title":"Tacrine-6-ferulic acid, a novel multifunctional dimer, inhibits amyloid-beta-mediated Alzheimer's disease-associated pathogenesis in vitro and in vivo","volume":"7","author":"Pi","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0775","doi-asserted-by":"crossref","first-page":"17170","DOI":"10.1074\/jbc.M109.004952","article-title":"The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology","volume":"284","author":"Podoly","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0780","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1021\/jm3017893","article-title":"Design and synthesis of new bifunctional sigma-1 selective ligands with antioxidant activity","volume":"56","author":"Prezzavento","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0785","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.bmc.2014.02.046","article-title":"Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease","volume":"22","author":"Pudlo","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0790","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijpharm.2014.10.058","article-title":"Synthesis, biological activity, and biopharmaceutical characterization of tacrine dimers as acetylcholinesterase inhibitors","volume":"477","author":"Qian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0795","first-page":"CD000202","article-title":"WITHDRAWN: Tacrine for Alzheimer's disease","author":"Qizilbash","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0800","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.03.021","article-title":"Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors","volume":"64","author":"Razavi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0805","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.054","article-title":"Butyrylcholinesterase and the cholinergic system","volume":"234","author":"Reid","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0810","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00894-012-1656-0","article-title":"In vitro inhibitory profile of NDGA against AChE and its in silico structural modifications based on ADME profile","volume":"19","author":"Remya","year":"2013","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0815","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.steroids.2013.08.003","article-title":"Synthesis and acetylcholinesterase inhibitory activity of polyhydroxylated sulfated steroids: structure\/activity studies","volume":"78","author":"Richmond","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0820","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/1389557513666131119201353","article-title":"Donepezil: an important prototype to the design of new drug candidates for Alzheimer's disease","volume":"14","author":"Rodrigues Simoes","year":"2014","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0825","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1016\/j.bmc.2005.07.019","article-title":"Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase","volume":"13","author":"Rodriguez-Franco","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0830","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.bmcl.2013.02.017","article-title":"Novel tacrine-related drugs as potential candidates for the treatment of Alzheimer's disease","volume":"23","author":"Romero","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0835","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1021\/jm1000024","article-title":"Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents","volume":"53","author":"Rook","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0840","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s11064-014-1250-1","article-title":"Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces","volume":"39","author":"Rosini","year":"2014","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0845","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.2174\/138161207781039788","article-title":"Disease modifying approaches for Alzheimer's pathology","volume":"13","author":"Sadowski","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0850","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1016\/j.ejmech.2011.05.048","article-title":"Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease","volume":"46","author":"Samadi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0855","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejmech.2013.06.021","article-title":"Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease","volume":"67","author":"Samadi","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0860","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejmech.2012.03.022","article-title":"Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine","volume":"52","author":"Samadi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0865","doi-asserted-by":"crossref","first-page":"5861","DOI":"10.1016\/j.bmc.2010.06.095","volume":"18","author":"Samadi","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0870","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/pro.661","article-title":"Backdoor opening mechanism in acetylcholinesterase based on X-ray crystallography and molecular dynamics simulations","volume":"20","author":"Sanson","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/jm0255668","article-title":"Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors","volume":"46","author":"Savini","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0880","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1016\/j.bmcl.2006.08.067","article-title":"6-Hydroxy- and 6-methoxy-beta-carbolines as acetyl- and butyrylcholinesterase inhibitors","volume":"16","author":"Schott","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0885","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0091-3057(97)00385-7","article-title":"Ameliorative effect of SA4503, a novel cognitive enhancer, on the basal forebrain lesion-induced impairment of the spatial learning performance in rats","volume":"59","author":"Senda","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0890","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(96)00572-9","article-title":"Ameliorating effect of SA4503, a novel sigma 1 receptor agonist, on memory impairments induced by cholinergic dysfunction in rats","volume":"315","author":"Senda","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0895","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1016\/j.bmcl.2004.07.005","article-title":"Synthesis and evaluation of tacrine-E2020 hybrids as acetylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"14","author":"Shao","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0900","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1021\/ar010025i","article-title":"Molecular dynamics of acetylcholinesterase","volume":"35","author":"Shen","year":"2002","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0905","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.bmcl.2005.05.132","article-title":"Design, synthesis, and evaluation of 2-phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors","volume":"15","author":"Sheng","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0910","doi-asserted-by":"crossref","first-page":"30905","DOI":"10.1074\/jbc.M303730200","article-title":"Nanosecond dynamics of the mouse acetylcholinesterase cys69-cys96 omega loop","volume":"278","author":"Shi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0915","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1021\/cn300178k","article-title":"Synthesis, pharmacological assessment, and molecular modeling of acetylcholinesterase\/butyrylcholinesterase inhibitors: effect against amyloid-beta-induced neurotoxicity","volume":"4","author":"Silva","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0920","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.1021\/jp502712d","article-title":"How is acetylcholinesterase phosphonylated by soman? An ab initio QM\/MM molecular dynamics study","volume":"118","author":"Sirin","year":"2014","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0925","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer's disease amyloid beta peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0930","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pnpbp.2013.02.001","article-title":"An update on amine oxidase inhibitors: multifaceted drugs","volume":"44","author":"Song","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0935","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1021\/np100654m","article-title":"Claurailas A-D, cytotoxic carbazole alkaloids from the roots of Clausena harmandiana","volume":"74","author":"Songsiang","year":"2011","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0940","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1021\/ci900491t","article-title":"Virtual screening discovery of new acetylcholinesterase inhibitors issued from CERMN chemical library","volume":"50","author":"Sopkova-de Oliveira Santos","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0945","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/138955712800493744","article-title":"Discovery of anti-Alzheimer agents: current ligand-based approaches toward the design of acetylcholinesterase inhibitors","volume":"12","author":"Speck-Planche","year":"2012","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0950","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2174\/092986712799945058","article-title":"Role of ligand-based drug design methodologies toward the discovery of new anti-Alzheimer agents: futures perspectives in fragment-based ligand design","volume":"19","author":"Speck-Planche","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0955","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.3390\/molecules18022397","article-title":"7-Methoxytacrine-adamantylamine heterodimers as cholinesterase inhibitors in Alzheimer's disease treatment \u2013 synthesis, biological evaluation and molecular modeling studies","volume":"18","author":"Spilovska","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0960","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1543-5946(04)90017-7","article-title":"Pharmacotherapeutic approaches to the prevention of Alzheimer's disease","volume":"2","author":"Standridge","year":"2004","journal-title":"Am. J. Geriatr. Pharmacother."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0965","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/13816128113199990026","article-title":"Effects of novel monoamine oxidases and cholinesterases targeting compounds on brain neurotransmitters and behavior in rat model of vascular dementia","volume":"20","author":"Stasiak","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0970","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1039\/b514859f","article-title":"Design of targeting ligands in medicinal inorganic chemistry","volume":"35","author":"Storr","year":"2006","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0975","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbi.2008.05.031","article-title":"The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis","volume":"175","author":"Sugimoto","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0980","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0960-894X(00)80547-8","article-title":"Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds","volume":"2","author":"Sugimoto","year":"1992","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0985","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1254\/jjp.89.7","article-title":"Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor","volume":"89","author":"Sugimoto","year":"2002","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0990","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/jm00169a008","article-title":"Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives","volume":"33","author":"Sugimoto","year":"1990","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib0995","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.bmc.2014.06.057","article-title":"Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, A\u03b2 aggregation, and beta-secretase","volume":"22","author":"Sun","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1000","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bmc.3173","article-title":"Determination of tacrine-6-ferulic acid in rat plasma by LC\u2013MS\/MS and its application to pharmacokinetics study","volume":"28","author":"Sun","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1005","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1016\/j.bmc.2013.09.050","article-title":"Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine\u2013Homoisoflavonoid hybrids","volume":"21","author":"Sun","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1010","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1016\/j.bmcl.2007.04.015","article-title":"Derivatives of oxoisoaporphine alkaloids: a novel class of selective acetylcholinesterase inhibitors","volume":"17","author":"Tang","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1015","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1016\/j.ejmech.2011.08.002","article-title":"Hybrids of oxoisoaporphine-tacrine congeners: novel acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation inhibitors","volume":"46","author":"Tang","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1020","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1074\/jbc.M408714200","article-title":"Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins","volume":"280","author":"Taniguchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1025","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1167\/iovs.07-1101","article-title":"Sigma-1 receptors protect RGC-5 cells from apoptosis by regulating intracellular calcium, Bax levels, and caspase-3 activation","volume":"49","author":"Tchedre","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrn2977","article-title":"The role of G protein-coupled receptors in the pathology of Alzheimer's disease","volume":"12","author":"Thathiah","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1035","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2014.01.020","article-title":"Synthesis, biological evaluation and molecular modeling study of novel tacrine-carbazole hybrids as potential multifunctional agents for the treatment of Alzheimer's disease","volume":"75","author":"Thiratmatrakul","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2008.03.020","article-title":"The chemical biology of nitric oxide: implications in cellular signaling","volume":"45","author":"Thomas","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1045","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/ci400196z","article-title":"Acetylcholinesterase inhibitors: structure based design, synthesis, pharmacophore modeling, and virtual screening","volume":"53","author":"Valasani","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/187152708784936626","article-title":"Beta-secretase: structure, function, and evolution","volume":"7","author":"Venugopal","year":"2008","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1055","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/jm401824w","article-title":"Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents","volume":"57","author":"Viayna","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejmech.2014.05.008","article-title":"Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations","volume":"81","author":"Vitorovic-Todorovic","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1065","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers \u2013 a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1070","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2014.04.078","article-title":"Donepezil+propargylamine+8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease","volume":"80","author":"Wang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1075","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmc.2012.08.040","article-title":"Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, beta-amyloid aggregation and Ca(2)(+) overload","volume":"20","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1080","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","article-title":"Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease","volume":"271","author":"Watkins","year":"1994","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1085","first-page":"285","article-title":"[Morpholinoethylamino-3 methyl-4 phenyl-6 pyridazine dihydrochloride (Agar 1240)]","volume":"13","author":"Wermuth","year":"1972","journal-title":"Agressologie"},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1090","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1016\/j.ejmech.2010.09.010","article-title":"Novel alkyl- and arylcarbamate derivatives with N-benzylpiperidine and N-benzylpiperazine moieties as cholinesterases inhibitors","volume":"45","author":"Wieckowska","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1095","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/07391102.2010.10507368","article-title":"Influence of the acetylcholinesterase active site protonation on omega loop and active site dynamics","volume":"28","author":"Wiesner","year":"2010","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1100","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1021\/ja00197a065","article-title":"Development of synthetic compounds with glutathione peroxidase activity","volume":"111","author":"Wilson","year":"1989","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1105","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1021\/ja971226d","article-title":"Molecular dynamics of acetylcholinesterase dimer complexed with tacrine","volume":"119","author":"Wlodek","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1110","article-title":"Donepezil-like multifunctional agents: design, synthesis, molecular modeling and biological evaluation","author":"Wu","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuint.2012.05.016","article-title":"Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake","volume":"61","author":"Xie","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2015.01.058","article-title":"Multifunctional tacrine-trolox hybrids for the treatment of Alzheimer's disease with cholinergic, antioxidant, neuroprotective and hepatoprotective properties","volume":"93","author":"Xie","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1125","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ejmech.2013.03.051","article-title":"Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease","volume":"64","author":"Xie","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1130","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1529\/biophysj.108.129601","article-title":"Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics","volume":"95","author":"Xu","year":"2008","journal-title":"Biophys. J."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1135","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2008.03.011","article-title":"Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site","volume":"44","author":"Zampieri","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1140","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bmcl.2014.01.032","article-title":"Synthesis and receptor binding studies of some new arylcarboxamide derivatives as sigma-1 ligands","volume":"24","author":"Zampieri","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1145","doi-asserted-by":"crossref","first-page":"5380","DOI":"10.1021\/jm900366z","article-title":"Synthesis, biological evaluation, and three-dimensional in silico pharmacophore model for sigma(1) receptor ligands based on a series of substituted benzo[d]oxazol-2(3H)-one derivatives","volume":"52","author":"Zampieri","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1150","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/ci300421n","article-title":"Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening","volume":"53","author":"Zhang","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1155","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1021\/jm800902t","article-title":"Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors","volume":"52","author":"Zhang","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1160","doi-asserted-by":"crossref","first-page":"10572","DOI":"10.1021\/ja020243m","article-title":"Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM\/MM study","volume":"124","author":"Zhang","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1165","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1021\/jm900504c","article-title":"Site-activated multifunctional chelator with acetylcholinesterase and neuroprotective\u2013neurorestorative moieties for Alzheimer's therapy","volume":"52","author":"Zheng","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-4422(04)00707-0","article-title":"Alzheimer's disease: the two-hit hypothesis","volume":"3","author":"Zhu","year":"2004","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1175","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.bmc.2008.12.067","article-title":"Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase","volume":"17","author":"Zhu","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.pneurobio.2015.12.003_bib1180","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejmech.2013.06.027","article-title":"Discovery of pyrazole as C-terminus of selective BACE1 inhibitors","volume":"68","author":"Zou","year":"2013","journal-title":"Eur. J. Med. Chem."}],"container-title":["Progress in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215001628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301008215001628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T04:41:54Z","timestamp":1748752914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301008215001628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":237,"alternative-id":["S0301008215001628"],"URL":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.12.003","relation":{},"ISSN":["0301-0082"],"issn-type":[{"value":"0301-0082","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Progress in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pneurobio.2015.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}